Aerovant Uses, Dosage, Side Effects and more
Aerovant, an IL4/13 receptor antagonist for severe asthma and eczema currently in Phase 2 studies.
| Trade Name | Aerovant |
| Generic | AER001 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in asthma.
